Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Senile plaques accumulate over the course of decades in the brains of patients with Alzheimer's disease. A fundamental tenet of the amyloid hypothesis of Alzheimer's disease is that the deposition of amyloid-beta precedes and induces the neuronal abnormalities that underlie dementia. This idea has been challenged, however, by the suggestion that alterations in axonal trafficking and morphological abnormalities precede and lead to senile plaques. The role of microglia in accelerating or retarding these processes has been uncertain. To investigate the temporal relation between plaque formation and the changes in local neuritic architecture, we used longitudinal in vivo multiphoton microscopy to sequentially image young APPswe/PS1d9xYFP (B6C3-YFP) transgenic mice. Here we show that plaques form extraordinarily quickly, over 24 h. Within 1-2 days of a new plaque's appearance, microglia are activated and recruited to the site. Progressive neuritic changes ensue, leading to increasingly dysmorphic neurites over the next days to weeks. These data establish plaques as a critical mediator of neuritic pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, the nidus of Aβ plaques develops from within neurites at a time course that could also fit that of plaque formation determined by multiphoton microscopy (MPM) occurring within a day [120].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the AD brain, microglia accumulate at the site of newly formed A deposits via migration or local proliferation and may help restrict plaque growth.4,5”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the brains of AD patients and APP-overexpressing mice, plaques are surrounded by reactive microglia and astrocytes (Meyer-Luehmann et al., 2008; Serrano-Pozo et al., 2013)”
From NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load (2021) · cites this paper as Meyer-Luehmann et al., 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Microglia appear rapidly (within one day) at the site of newly formed plaques [78].”
From Microglial dysfunction in brain aging and Alzheimer's disease (2014) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“Remarkably, this MPM study of AD transgenic mouse brain in vivo also described the emergence of dystrophic neurites in areas distant from plaques that appeared and, at times, even disappeared, although intraneuronal Aβ was not examined in these neurites.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [120]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“It is possible that submicroscopic nuclei may be present in the cortex 23 , perhaps related to the recently reported amyloid-β oligomeric forms 24,25 , as precursors to this sudden growth.”
BackgroundRetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · cited 2×
“These data thus lead to a model consistent with a prediction of the amyloid hypothesis in which amyloid deposition, activation and recruitment of microglia and local neuritic changes play out as a sequential cascade leading to neurodegeneration 1 .”
BackgroundResultWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“It is possible that submicroscopic nuclei may be present in the cortex 23 , perhaps related to the recently reported amyloid-β oligomeric forms 24,25 , as precursors to this sudden growth.”
BackgroundCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 3×
“To examine whether the phenotype of plaque formation in as short a period as one week was unique to the aggressive APP/PS1 transgenic mouse model, we used a mouse line that has a slower progression of disease (Tg2576) 7 .”
BackgroundMethodImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 3×
“In addition, homozygous PDAPP mice 16 were crossed with homozygous CX3CR1-GFP mice 17 , and two female PDAPP +/ − ×CX3CR1-GFP +/ − transgenic mice at the age of 18 months were used in this study and imaged for three consecutive days.”
BackgroundMethodJarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178 · cited 1×
“These results are surprising because it has been generally accepted, based on in vitro studies of protein aggregation, that amyloid-β aggregation is time dependent and follows a relatively slow nucleation-dependent polymerization process 22 .”
ResultJankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265 · cited 1×
“It has been proposed that activated microglia clear amyloid deposits 13 , are the nidus for initiation of amyloid fibrils 14 or restrict plaques 15 .”
Background
Cited by
Items 801–900 of 995
Murakami, K., Horii, S., Hanaki, M., & Irie, K. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00489 · Cited by 7
Luo, Z., Xu, H., Samanta, S., Zhang, R., Luo, G., Wang, Y., Liu, L., Weng, X., He, J., Liao, C., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10112949 · Cited by 8
“[6] reported that Aβ plaques can rapidly appear from monomeric Aβ peptides within 24 h, and can even remain stable in size for the next 14 days, as confirmed by imaging studies.”
BackgroundNanoscale reorganisation of synaptic proteins in Alzheimer's disease
Zhu, W., Yang, X., Gou, X., Fu, S., Chen, J., Gao, F., Shen, Y., Bi, D., & Tang, A. (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12924 · Cited by 6
Kuznetsov, A. V. (2025) · Journal of Biomechanical Engineering · doi:10.1115/1.4067701 · Cited by 7
Ms4a4a deficiency ameliorates plaque pathology in a mouse model of amyloid accumulation
Danhash, E., Verbeck, A. C., Western, D., Díaz‐Pacheco, A. S., Galasso, G., You, S., Huang, G., Starr, E., Miller, N., Nadarajah, C. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70580 · Cited by 8
Neupane, S., & Hortobágyi, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411811 · Cited by 6
Wang, L., Lin, H., Chao, C., Lin, M.-T., Wang, L., Chein, L.-H., Chang, C., & Chio, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-26463-w · Cited by 8
Neuroinflammation in Alzheimer's, Parkinson's and Huntington's Diseases
Sastre, M., Katsouri, L., Birch, A. M., Renziehausen, A., Dexter, D. T., Crichton, R. R., & Ward, R. J. (2014) · Wiley eBooks · doi:10.1002/9781118406557.ch6 · Cited by 8
Proteomics of spatially identified tissues in whole organsPreprint
Bhatia, H. S., Brunner, A., Rong, Z., Mai, H., Thielert, M., Al-Maskari, R., Paetzold, J. C., Kofler, F., Todorov, M. I., Ali, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.02.466753 · Cited by 6
“Scalable and robust pathology identification using deep learning One of the early hallmarks of Alzheimer’s disease (AD) pathology is the accumulation of amyloid-beta (Aβ) plaques in the brain parenchyma (Meyer-Luehmann et al., 2008).”
BackgroundImage post-processing for SILMAS: structured illumination light sheet microscopy with axial sweeping
Frantz, D., Wright, C. J., Schaser, A. J., Kirik, D., Kristensson, E., & Berrocal, E. (2024) · Biomedical Optics Express · doi:10.1364/boe.531210 · Cited by 5
Vaneev, A. N., Gorelkin, P. V., Barykin, E. P., Колмогоров, В., Timoshenko, R. V., Mitkevich, V. A., Petrushanko, I. Y., Varshavskaya, K. B., Salikhov, S. V., Klyachko, N. L., et al. (2024) · ChemBioChem · doi:10.1002/cbic.202400786 · Cited by 7
Wood, J. I., Dulewicz, M., Szadziewska, A., Weiner, S., Ge, J., Stringer, K. M., Desai, S., Fenson, L., Piotrowska, D., Brinkmalm, G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63328-y · Cited by 14
Donev, R., & Howell, O. W. (2012) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-394287-6.00004-5 · Cited by 5
Zhao, K.-P., Wang, X., Shao, M.-Q., He, C.-Y., & Yuan, F. (2023) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320231184988 · Cited by 9
“Aβ is the main component of amyloid cores in senile plaques, and the accumulation and deposition of Aβ is a significant cause of AD.(38) Herein, our study found that the downregulation of XIST in the hippocampus improved the spatial learning and memory capability of APP/ PS1 mice.”
BackgroundThe Role of Hyperbaric Oxygen Therapy in Neuroregeneration and Neuroprotection: A Review
Barata, P., Camacho, O. E., Lima, C. G., & Pereira, A. C. (2024) · Cureus · doi:10.7759/cureus.62067 · Cited by 11
Kuznetsov, A. V. (2024) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2024.111900 · Cited by 5
Pore-Forming Neurotoxin-Like Mechanism for Aβ Oligomer-Induced Synaptic Failure
Aguayo, L. G., Parodí, J., Sepúlveda, F. J., & Opazo, C. (2009) · Springer eBooks · doi:10.1007/978-0-387-87995-6_2 · Cited by 5
Alzheimer’s Disease: Clinical Trials and the Amyloid Hypothesis
Cummings, J. L. (2011) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v40n7p304 · Cited by 7
1700 nm broadband laser source enables deep brain optical biopsy
Tang, P., & Wang, R. K. (2021) · Light Science & Applications · doi:10.1038/s41377-021-00652-0 · Cited by 5
Neuroglia in Neurological Diseases
Verkhratsky, A., & Butt, A. M. (2013) · Wiley eBooks · doi:10.1002/9781118402061.ch10 · Cited by 6
Gao, C., Lin, Z., Chen, Y., Gan, R., Wang, K., He, X., & Han, H. (2025) · Neuropharmacology and Therapy · doi:10.15212/npt-2025-0015 · Cited by 8
“In the context of neurodegenerative disease models, long-term in vivo imaging has directly visualized microglia interacting with pathology, for instance, by migrating toward and phagocytosing amyloid plaques over weeks to months [97].”
Alzheimer’s Disease: Evolving Therapeutics, Scientific Progress, and Key Challenges
Sai Yasasvi, K., Goswami, A. K., Prasad, M. R., Chauhan, V. S., & Yadav, N. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02468 · Cited by 7
Novel inflammatory and insulin resistance indices provide a clue in cerebral amyloid angiopathy
Zhu, H., Wang, Y., He, L.-C., Luo, H., Zong, C., Yang, Y., Wu, J.-H., Song, B., Gao, Y., Xu, Y., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-62280-z · Cited by 4
Zhang, T., Sun, J., Jiao, Q., Li, S., Meng, X., Shi, J., & Wang, B. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.08.004 · Cited by 4
Lee, R., Kim, G., Black, E. R., & Kim, S. (2026) · Advanced Science · doi:10.1002/advs.77858 · Cited by 5
Pregabalin Treatment does not Affect Amyloid Pathology in 5XFAD Mice
Sadleir, K. R., Popovoic, J., Zhu, W., Reidel, C. T., Do, H., Silverman, R. B., & Vassar, R. J. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210713125333 · Cited by 4
Crockett, A. M., Fuhrmann, M., Garaschuk, O., & Davalos, D. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_5 · Cited by 4
Kuznetsov, I. A., & Kuznetsov, A. V. (2019) · Journal of Biomechanical Engineering · doi:10.1115/1.4041905 · Cited by 4
Defining the Neuropathological Aggresome across in Silico, in Vitro, and ex Vivo Experiments
Gomes, G.-N. W., & Levine, Z. A. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c09193 · Cited by 4
Muralidharan, K. K., Karumanchi, S., Kowalski, K. G., Burkett, P., Chapel, S. H., Rajagovindan, R., & Nestorov, I. A. (2022) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2047 · Cited by 4
Malyshev, I. Y. (2013) · SpringerBriefs in biochemistry and molecular biology · doi:10.1007/978-94-007-5943-5_8 · Cited by 4
Ottersen, O. P. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00350.x · Cited by 6
Amyloid‐Like Fibrils: Origin, Structure, Properties, and Potential Technological Applications
Taboada, P., Barbosa, S., Juárez, J., Alatorre‐Meda, M., & Mosquera, V. (2013) · Wiley eBooks · doi:10.1002/9781118523063.ch12 · Cited by 6
The Role of Aβ in Alzheimer's Disease
Ryan, T. M., Roberts, B. R., Streltsov, V. A., Nuttall, S. D., & Masters, C. L. (2013) · Wiley eBooks · doi:10.1002/9783527654185.ch13 · Cited by 6
Wood, J. I., Dulewicz, M., Ge, J., Stringer, K. M., Szadziewska, A., Desai, S., Koutarapu, S., Hajar, H. B., Blennow, K., Zetterberg, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.08.617019 · Cited by 5
Liu, L., Li, L., Lu, L., Fan, S., Liu, L.-Z., He, R.-B., Li, H., Xian, X., & Li, W. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01900-w · Cited by 4
Unmasking early microglial remodeling in an Alzheimer’s disease mouse model
Saminathan, P., McArdle, S., Corey, M., Nadig, N., Fang, C., Gibbons, A., Rayadurgam, M., & Sharma, S. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1720382 · Cited by 3
Bifurcations in coupled amyloid-β aggregation-inflammation systems
Chakrabarti, K. S., Bakhtiari, D., & Rezaei‐Ghaleh, N. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00408-7 · Cited by 4
APP Modulates Aβ-Induced Activation of Microglia in Mouse Model of Alzheimer's Disease
Datta, D. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3122-16.2017 · Cited by 3
“Recruitment of microglia to newly formed A plaques occurs rapidly, and there appears to be a dynamic interaction between A and immune-related pathways (Bolmont et al., 2008; Meyer-Luehmann et al., 2008).”
BackgroundEffect of Microglial Inflammation in Prion Disease
Ano, Y., Sakudo, A., & Onodera, T. (2019) · Current Issues in Molecular Biology · doi:10.21775/cimb.036.001 · Cited by 4
Neurochemical Aspects of Alzheimer’s Type of Dementia
Farooqui, A. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816347-4.00003-9 · Cited by 4
Huo, Y., Huang, S., Li, R., Gong, X., Zhang, W., Zhang, R., & Qin, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-82327-9 · Cited by 4
Actions of Bioactive Phytochemicals in Cell Function and Alzheimer’s Disease Pathology
Hartman, R. E. (2009) · Oxidative stress and disease · doi:10.1201/9781420073522.ch16 · Cited by 5
Single Molecule Spectroscopy Illuminating the Molecular Dynamics of Life
Webb, W. W. (2009) · Springer series in chemical physics · doi:10.1007/978-3-642-02597-6_5 · Cited by 3
NHE6-Depletion Corrects ApoE4-Mediated Synaptic Impairments and Reduces Amyloid Plaque LoadPreprint
Pohlkamp, T., Xian, X., Wong, C. H. Y., Durakoglugil, M. S., Werthmann, G. C., Saido, T., Evers, B. M., White, C. L., Connor, J., Hammer, R. E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.22.436385 · Cited by 4
A novel hybrid protein promotes Aβ clearance and reduces inflammatory response through MerTKPreprint
Samentar, L., Salazar, A., Pan, P., Etebar, K., Choy, K., Uddin, D., Eliseeff, P., Bugayong, A. M., Garrido, J. A. M. G., Emini, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.03.467048 · Cited by 2
Jager, R. M. D., Lee, A., Sigalov, A., & Taga, M. F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.01.577128 · Cited by 3
Glia in Neurodegenerative Disease
Crowley, G., Attwell, D., Phatnani, H. P., Sontheimer, H. W., & Hong, S. Y. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041375 · Cited by 3
Rao, N. R., DeGulis, O. A., Nomura, T., Lee, S., Hark, T. J., Dynes, J. C., Dexter, E. X., Dulewicz, M., Ge, J., Upadhyay, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.28.620698 · Cited by 3
Optical histopathology based on the nonlabeling analysis with multiphoton excitation imaging
Matsui, T. (2024) · Pathology International · doi:10.1111/pin.13498 · Cited by 2
Predicting biological age using an accumulated neurotoxicity biomarker for amyloid beta oligomers
Kuznetsov, A. V. (2026) · Mathematical Medicine and Biology A Journal of the IMA · doi:10.1093/imammb/dqag005 · Cited by 4
Rao, N. R., Santiago-Marrero, I. G., DeGulis, O. A., Nomura, T., Goyal, K., Lee, S., Hark, T. J., Dynes, J. C., Dexter, E., Dulewicz, M., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adp3984 · Cited by 7
Zou, M., Zhao, T., Wu, W., Zhang, J. Y., Pan, P., Yan, J., Li, Q., & Zhou, Y. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03946-5 · Cited by 2
Hyeon, S. J., Kim, S. C., Chu, J., Kim, Y., Kim, C., Park, U., Tufail, Z., Nguyen, P. T., Eom, A., Kim, S., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02789-z · Cited by 3
Traumatic Injury Reduces Amyloid Plaque Burden in the Transgenic 5xFAD Alzheimer’s Mouse Spinal Cord
Chu, T., Cummins, K., & Stys, P. K. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200387 · Cited by 2
Hajda, A., Petrusevich, E. F., Zaleśny, R., Ośmiałowski, B., & Olesiak‐Bańska, J. (2025) · Chemical Communications · doi:10.1039/d5cc00243e · Cited by 4
Hushmandi, K., Reiter, R. J., Farahani, N., Cho, W. C. S., Alimohammadi, M., & Khoshnazar, S. M. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111325 · Cited by 2
Davalos, D., & Fuhrmann, M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1429-6_4 · Cited by 2
Pin1 Protects Against Alzheimer's Disease: One Goal, Multiple Mechanisms
Pastorino, L., Kondo, A., Zhen, X., & Lu, K. P. (2013) · InTech eBooks · doi:10.5772/55085 · Cited by 4
“Both plaques and tangles are considered causative of the disease; they deposit following the progression of the disease, and they could contribute to alter neuronal morphology leading to neuronal death [12-16].”
BackgroundBiomarkers in the Diagnosis and Treatment of Alzheimer’s Disease: Potential and Pitfalls
McCorquodale, D. S., & Myers, A. (2008) · Biomarkers in Medicine · doi:10.2217/17520363.2.3.209 · Cited by 3
“Indeed, while the latest evidence indicates that Aβ acts upstream of Tau [8] in a unidirectional fashion [9,10], indicating that Aβ toxicity is ancedent to Tau, including Tau and p-Tau as a molecular biomarker in the analysis of cerebral spinal fluid (CSF) increased the specificity of these tests [11].”
BackgroundL’homéopathie ouvre de nouvelles voies de recherche dans la maladie d’Alzheimer
Billot, J.-P. (2012) · La Revue d Homéopathie · doi:10.1016/j.revhom.2012.07.001 · Cited by 2
Boyd, T. D. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.1962 · Cited by 2
“Conversely, it has also been shown that amyloid plaques form rapidly and then become decorated by microglia [13,14], both resident and bone marrow-derived, suggesting an ability and intention to remove amyloid [15–17].”
BackgroundIntravital imaging of dendritic spine plasticity
Lai, C. S. W. (2014) · IntraVital · doi:10.4161/21659087.2014.984504 · Cited by 2
Biomedical in vivo Optical Imaging for Disease Espying and Diagnosis
Safi, A. M., & Chung, E. (2015) · Biosystems & biorobotics · doi:10.1007/978-3-319-21813-7_14 · Cited by 2
Membrane-Spanning 4-Domains Subfamily A, MS4A Cluster
Brown, K. S., Turton, J. C., & Morgan, K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7309-1_8 · Cited by 3
Community Mediation Service: A Model for Teaching Democracy and Conflict Resolution.
Slaton, C. D. (1994) · Cited by 2
Amyloid fibrils are nanoparticles that target lysosomes.
Jakhria, T. (2014) · UPT. Syiah Kuala University Library (Syiah Kuala University) · Cited by 2
Protein Aggregation in Neurodegeneration
Aguzzi, A., & Kana, V. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch4 · Cited by 3
New amyloid plaques or a game of hide-and-seek?
Zou, K., Maeda, T., Michikawa, M., & Komano, H. (2008) · International Journal of Biological Sciences · doi:10.7150/ijbs.4.200 · Cited by 2
Mishra, P., Silva, A., Sharma, J., Nguyen, J., Pizzo, D. P., Sahoo, D., & Cherqui, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1602615/v1 · Cited by 2
Zarrouk, A. (2013) · theses.fr (ABES) · doi:10.70675/0ca0afb8z8b2cz4b48zb97az382f4a6003ba · Cited by 4
Nelson, R. B. (2010) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(10)45019-8 · Cited by 2
Vesicular Transport and Amyloids: The Growing Relationship
Upadhyay, A. (2024) · Biologics · doi:10.3390/biologics4040023 · Cited by 1
A Network-Based Study of the Dynamics of Aβ and τ Proteins in Alzheimer’s Disease
Bianchi, S., Landi, G., Marella, C., Tesi, M. C., Testa, C. M., & Initiative, A. D. N. (2024) · Mathematical and Computational Applications · doi:10.3390/mca29060113 · Cited by 2
EGR2 maintains neuropathic pain by promoting microglial phagocytosis.
Xi, C., Zhang, J., Huang, Z., He, L., Zou, K., Xu, X., Guo, Q., Sun, B., & Huang, C. (2025) · PubMed Central · doi:10.11817/j.issn.1672-7347.2025.240270 · Cited by 3
Sialylation patterns in cerebral amyloid angiopathy
Fastenau, C., Crisp, R., Keating, M., Ochoa, E., Richardson, T. E., Flanagan, M. E., Walker, J. M., Hopp, S. C., & Bieniek, K. F. (2025) · Brain Pathology · doi:10.1111/bpa.70042 · Cited by 2
Yu, R., Suraev, A. S., Vidal, V., Kong, S. D., Zachariae, R. H., Piccio, L. M., Heneka, M. T., Naismith, S. L., & Michaelian, J. C. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03787-x · Cited by 1
Spreading of pathological proteins through brain networks: A case study for Alzheimer's disease
Landi, G., Scaravelli, A., Tesi, M. C., & Testa, C. M. (2026) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2026024 · Cited by 1
“Since Aβ protein is known to travel on short distances in the extracellular space [20], we constructed what we called the “intrinsic proximity graph”, as follows.”
InfluentialNastenko, A. A., Колмогоров, В., Vaneev, A. N., Gorelkin, P. V., Klyachko, N. L., & Erofeev, A. S. (2026) · Analytical Methods · doi:10.1039/d5ay01889g · Cited by 3
Lim, J. Y., Lee, J. E., Lee, M., Shim, H., Park, S. I., Park, S. A., Jeun, S.-S., Wang, S.-M., Kim, S., Yang, S. H., et al. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00539-3 · Cited by 2
“They interfere with synaptic function, impair neuronal communication, and induce inflammation and oxidative stress [71].”
Nanoscale imaging of neurotoxic proteins
Kaminski, C. F., Pinotsi, D., Michel, C. H., & Schierle, G. S. K. (2014) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2062721 · Cited by 1
Ashraf, A., Mehta, P. D., & Edison, P. (2012) · Reviews in Clinical Gerontology · doi:10.1017/s0959259812000160 · Cited by 1
Immune Senescence and Inflammaging in Neurological Diseases
Baden, P., Cicco, S. D., Yu, C., & Deleidi, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_143 · Cited by 1
In Vivo Imaging in Neurodegenerative Diseases
Wang, X., Arbel‐Ornath, M., Wegmann, S., Kastanenka, K. V., & Bacskai, B. J. (2014) · Springer eBooks · doi:10.1007/978-94-017-9361-2_3 · Cited by 1
Self-citationElectron microscopist's view of the Alzheimer's plaque
Dikranian, K. T. (2012) · Biomedical Reviews · doi:10.14748/bmr.v23.25 · Cited by 3
Imaging Morphology and Function of Cortical Microglia
Brawek, B., & Garaschuk, O. (2013) · Neuromethods · doi:10.1007/978-1-62703-785-3_13 · Cited by 1
Alzheimer Disease: Protein Misfolding, Model Systems, and Experimental Therapeutics
Price, D. L., Savonenko, A. V., Li, T., Lee, M. K., & Wong, P. C. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch12 · Cited by 1
Heparan Sulfate in the Amyloidosis and Inflammation of Alzheimer’s Disease
O′Callaghan, P. W. (2011) · Uppsala University Publications (Uppsala University) · Cited by 1
Shorter, J. (2011) · Wiley eBooks · doi:10.1002/9781118063903.ch7 · Cited by 2
“In a mouse AD model, β-amyloid (Aβ) plaques can form rapidly and • Q1 mediate pathology (Meyer-Luehmann et al., 2008).”
BackgroundSialic Acid‐Modified Nanoparticles for β‐Amyloid Studies
Kouyoumdjian, H., & Huang, X. (2015) · Wiley eBooks · doi:10.1002/9781118860212.ch12 · Cited by 1
Yang, J., Ding, W., Zhu, B., Zhen, S. Y., Kuang, S., Zhang, C. M., Wang, P., Yang, F., Yang, L., Yin, W. H., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.05.447217 · Cited by 1
Tuning gene expression to music: the compensatory effect of music on age-related cognitive disordersPreprint
Gómez‐Carballa, A., Navarro, L., Pardo‐Seco, J., Bello, X., Pischedda, S., Viz-Lasheras, S., Camino‐Mera, A., Currás-Tuala, M. J., Ferreirós-Vidal, I., Mallah, N., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.12.557408 · Cited by 1
A network based study of the dynamics of Aβ and τ proteins in Alzheimer’s diseasePreprint
Bianchi, S., Landi, G., Marella, C., Tesi, M. C., Testa, C. M., & Initiative, A. D. N. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.17.618808 · Cited by 1
Kuznetsov, A. V. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.03.621770 · Cited by 1
Synapses, spines, zinc and pathology of Alzheimer's disease.
Familtsev, D. (2013) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/420 · Cited by 1
The dynamic nature of amyloid-beta protein aggregation and its association to Alzheimer’s disease
Vilaprinyó-Pascual, S. (2015) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
The Role of Apolipoprotein E Concentration and Isoform in Amyloid-beta Metabolism In Vivo
Castellano, J. M. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7416v3s
“…with various toxic effects in the brain, including neuritic dystrophy, synaptic and network dysfunction, and neuroinflammation (Bolmont et al., 2008; Busche et al., 2008; D'Amore et al., 2003; Knowles et al., 1999; Kuchibhotla et al., 2008; Lombardo et al., 2003; Meyer-Luehmann et al., 2008).”
BackgroundMicroglial properties in health and disease
Krabbe, G. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-15999
Characterization of HDAC4's role in brain
Darcy, M. (2010)
Animal Models to Study the Biology of Amyloid‐β Protein Misfolding in Alzheimer Disease
Ashe, K. H. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch11
Metadata
- Authors
- Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T.
- Affiliations
- Harvard University (US)
- Washington University in St. Louis (US)
- Corresponding author
- Hyman, Bradley T.
- Venue
- Nature
- Published
- 2008-02
- Volume
- 451
- Issue
- 7179
- Pages
- 720-724
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3264491
- OpenAlex
- W2107015337
- Cited by
- 987
- References
- 27
- Citations by year
- 2026: 27 · 2025: 25 · 2024: 45 · 2023: 38 · 2022: 45 · 2021: 56 · 2020: 43 · 2019: 40 · 2018: 37 · 2017: 36 · 2016: 57 · 2015: 51 · 2014: 48 · 2013: 62 · 2012: 83
- FWCI
- 66.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Alzheimer's Association
- University of Pittsburgh
- National Institutes of Health
- National Institute on Aging (R01AG008487, P50AG005134, P30AG062421)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056341)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid plaques, microglial activation, microglial recruitment, APP/PS1 mice, amyloid hypothesis, cortical degeneration
- MeSH terms
- Alzheimer Disease, Animals, Axons, Disease Models, Animal, Mice, Transgenic, Time Factors, Amyloid beta-Peptides, Neurites, Microglia, Disease Progression, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.